# Wolf Creek XVIII Part 4: innovations in ECPR technology

**Authors:** Georg Trummer, Demetris Yannopoulos, Yohei Okada

PMC · DOI: 10.1016/j.resplu.2026.101274 · Resuscitation Plus · 2026-02-19

## TL;DR

This paper discusses recent innovations in ECPR technology and highlights the challenges in standardizing and implementing it for cardiac arrest resuscitation.

## Contribution

The paper contributes a focused discussion on current innovations and barriers in ECPR technology from an international conference.

## Key findings

- ECPR is promising but lacks standardized protocols and faces implementation challenges.
- Current ECPR is highly individualized, making it hard to conduct large-scale trials.
- Targeted research and community studies are needed to improve ECPR outcomes.

## Abstract

The 50th Anniversary Wolf Creek XVIII Conference was hosted by the Max Harry Weil Institute for Critical Care Research and Innovation in Ann Arbor, Michigan, USA on June 19–21, 2025. “Innovations in ECPR Technology” was one topic of focused presentation and discussion by invited panelists and conference participants made up of international academic and industry scientists as well as thought leaders in the field of cardiac arrest resuscitation.

This panel was part of the conference agenda in order to update the auditorium on the current state of the art of ECPR increasingly offered by specialized centers worldwide but still far away from routine use. In view of the ongoing high mortality and morbidity of patients treated with CPR following cardiac arrest, ECPR arises as a potential promise to improve this challenge, however many questions with respect to patient selection, implementation and the required related technical and educational resources are currently not solved and remain as relevant barriers. Moreover, current ECPR does not follow standardized protocols and is therefore a highly individualized therapy of each performing center. This is a relevant barrier in order to conduct trials with larger and more homogenous groups of patients. Despite the tempting option to overcome the shortcomings of CPR, the field of ECPR primarily requires targeted research with focus on community studies and the rationale implementation of extracorporeal circulation in the CPR scenario.

## Linked entities

- **Diseases:** cardiac arrest (MONDO:0000745)

## Full-text entities

- **Genes:** COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}
- **Diseases:** ischemia reperfusion injury (MESH:D015427), death (MESH:D003643), post (MESH:D000094025), heart rhythms (MESH:D006331), ventricular fibrillation (MESH:D014693), ALS (MESH:D008113), circulatory arrest (MESH:D012769), OHCA (MESH:D058687), cardiotomy failure (MESH:D051437), cardiac arrest (MESH:D006323), Sudden cardiac arrest (MESH:D016757), ischemia (MESH:D007511)
- **Chemicals:** CARL (-), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964275/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12964275/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964275/full.md

---
Source: https://tomesphere.com/paper/PMC12964275